Citi analyst predicts an Apple foldable iPhone launch this year, potentially priced at $2,000. Learn about the projected ...

Revolution Medicines acquisition talks with Merck could value the biotech at up to $32B. RVMD stock soared over 15% on news ...

Revvity Q4 results exceeded expectations, driving a 6% stock gain. The life sciences company also issued an upbeat 2026 ...

Nike could soon achieve Nike dividend aristocrat status, marking 25 years of growth. This move could attract income investors ...

AppFolio insider selling by executives contrasts with significant institutional buying. Quantum Portfolio Management boosted ...

Paylocity analyst ratings show a 'Moderate Buy' consensus with a $204 price target. Discover why Wall Street is optimistic ...

Stryker analyst upgrade by Raymond James boosts SYK stock 4.1%. Firm sees attractive entry point after valuation compression ...

Teleflex CEO departs, with an interim CEO appointed as the company searches for a permanent chief. This comes alongside a ...

CNA Financial underperformed the market. An analyst report highlights CNA growth concerns, citing weak premiums, EPS, and ...

New Neurocrine INGREZZA data reveals nearly two-fold higher target occupancy vs. AUSTEDO XR. This reinforces its competitive ...

Best Buy short interest rose 20.4% in December, signaling bearish sentiment. Yet, BBY reported strong earnings, upbeat ...

SG Americas significantly increased its PB stake, boosting holdings by 634%. This PB stake increase, alongside a dividend ...